Offer An Article

Pandemic Latest News

AstraZeneca

Covishield: A single dose may be enough for those previously infected with COVID-19

New research claims that a single dose of Covishield may be sufficient to protect those previously infected with the novel coronavirus which causes COVID-19.  If someone has previously contracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV), researchers at the Assam Medical College and the Indian Council of Medical Research (ICMR) suggest that they may not …

Covishield: A single dose may be enough for those previously infected with COVID-19 Read More »

AstraZeneca medicine approved for kidney disease treatment

Chronic kidney disease (CKD) is an often neglected condition. Hope may be on the horizon as a medication has been approved in India produced by AstraZeneca.  The medication, dapagliflozin, is an AstraZeneca-produced medication that has previously been approved for use in the treatment of diabetes. The drug has, however, shown to have a high degree …

AstraZeneca medicine approved for kidney disease treatment Read More »